Sign in

CIK 0001549595

  • Large accelerated filer

Nurix Therapeutics, Inc.

Sign in to watch
Ticker
NRIX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Nov 30
Incorporated
DE
Entity type
Operating
EIN
270838048
Phone
+1 415-660-5320
Business address
1600 SIERRA POINT PKWY, BRISBANE, CA, 94005
Former names
Nurix, Inc.
  1. 4 Derivatives Options or other derivatives
  2. 4 Derivatives Options or other derivatives
  3. 4 Open-market sale General Counsel sold 1,200 shares at $27.00 ($32,400)
  4. 4 Open-market sale Chief Business Officer sold 7,500 shares at an average $26.49 ($198,644)
  5. 4 Other disposition 10% owner disposed of 1,085,784 shares (other)
  6. 4 Other disposition 10% owner disposed of 3,488,027 shares (other)
  7. 4 Other disposition 10% owner disposed of 3,488,027 shares (other)
  8. 4 Open-market sale Chief Scientific Officer sold 800 shares at $35.00 ($27,996)
  9. 4 Open-market sale General Counsel sold 800 shares at $35.25 ($28,200)
  10. 4 Open-market sale General Counsel sold 1,200 shares at $27.20 ($32,640)
  11. 4 Open-market sale Chief Business Officer sold 7,500 shares at an average $27.28 ($204,632)
  12. 4 Open-market sale Chief Scientific Officer sold 400 shares at $35.00 ($14,000)
  13. 4 Open-market sale Chief Scientific Officer sold 400 shares at $31.55 ($12,620)
  14. 4 Exercise or conversion Chief Business Officer acquired 4,330 shares (option exercise)
  15. 4 Open-market sale Chief Scientific Officer sold 800 shares at $45.00 ($36,000)
  16. 4 Open-market sale General Counsel sold 2,000 shares at an average $41.27 ($82,539)
  17. 4 Open-market sale Chief Business Officer sold 7,500 shares at an average $37.02 ($277,678)
  18. 4 Open-market sale Chief Scientific Officer sold 800 shares at $35.95 ($28,760)
  19. 4 Open-market sale Chief Financial Officer sold 35,419 shares at $39.90 ($1,413,218)
  20. 4 Open-market sale Chief Financial Officer sold 5,330 shares at $39.93 ($212,839)

Page 12 of 14 · 274 filings